MarketCap
Facebook
X
TelegramAnnual report 2024
added 11-29-2025
Trinity Biotech plc Market Cap 2011-2025 | TRIB
As of December 05, 2025 Trinity Biotech plc has a market cap of $ 61.9 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Trinity Biotech plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 120 M | 79.6 M | 86.1 M | 191 M | 441 M | 604 M | 1.16 B | 1.74 B | 2.39 B | 1.38 B | 874 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.39 B | 79.6 M | 824 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aspira Women's Health
AWH
|
45.4 M | - | -6.19 % | $ 10.5 M |  USA |
 |
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
4.33 M | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
48.8 B | $ 64.79 | 2.0 % | $ 25 B | USA |
 |
Brainsway Ltd.
BWAY
|
240 M | $ 17.23 | 1.5 % | $ 99.4 M | Israel |
 |
Burning Rock Biotech Limited
BNR
|
2.95 B | $ 21.15 | 11.37 % | $ 233 M |  China |
 |
Enzo Biochem
ENZ
|
57.5 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
9.32 B | $ 101.24 | 0.04 % | $ 18.8 B | USA |
 |
Biomerica
BMRA
|
7.19 M | $ 2.31 | 2.01 % | $ 5.31 M | USA |
 |
BioNano Genomics
BNGO
|
3.55 M | $ 1.69 | -1.74 % | $ 2.15 M | USA |
 |
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
34.9 M | $ 0.36 | -0.39 % | $ 10.6 M | USA |
 |
Guardant Health
GH
|
5.84 B | $ 104.81 | -0.39 % | $ 12.9 B | USA |
 |
Celcuity
CELC
|
399 M | $ 98.24 | -0.25 % | $ 3.88 B | USA |
 |
DarioHealth Corp.
DRIO
|
43.4 M | $ 11.75 | -0.47 % | $ 333 M | Israel |
 |
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
16.6 B | $ 185.09 | 2.99 % | $ 15.3 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
37.7 B | $ 733.11 | 0.57 % | $ 60.5 B | USA |
 |
Danaher Corporation
DHR
|
152 B | $ 228.08 | 1.74 % | $ 167 B | USA |
 |
Illumina
ILMN
|
16.4 B | $ 128.88 | 0.12 % | $ 20.5 B | USA |
 |
Anixa Biosciences
ANIX
|
70.8 K | $ 4.25 | -3.41 % | $ 136 K | USA |
 |
Laboratory Corporation of America Holdings
LH
|
21.1 B | $ 267.33 | -0.14 % | $ 22.4 B | USA |
 |
Lantheus Holdings
LNTH
|
6.47 B | $ 58.6 | -0.81 % | $ 4.06 B | USA |
 |
Accelerate Diagnostics
AXDX
|
40.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
10.2 B | $ 589.45 | 0.25 % | $ 18.2 B | USA |
 |
Mettler-Toledo International
MTD
|
29.9 B | $ 1 457.09 | -0.75 % | $ 30.9 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
973 M | $ 7.06 | -0.03 % | $ 640 M | USA |
 |
ENDRA Life Sciences
NDRA
|
2.2 M | $ 5.81 | -1.43 % | $ 3.12 M | USA |
 |
NeoGenomics
NEO
|
1.53 B | $ 12.02 | -0.04 % | $ 1.52 B | USA |
 |
Neogen Corporation
NEOG
|
1.02 B | $ 5.91 | -0.25 % | $ 1.28 B | USA |
|
Biodesix
BDSX
|
92.1 M | $ 7.79 | - | $ 1.01 B | USA |
 |
National Research Corporation
NRC
|
1.01 B | $ 16.27 | -3.1 % | $ 399 M | USA |
 |
Natera
NTRA
|
5.31 B | $ 237.72 | 1.48 % | $ 23.4 B | USA |
 |
Invitae Corporation
NVTA
|
511 M | - | - | $ 21.2 M | USA |
 |
Castle Biosciences
CSTL
|
709 M | $ 39.24 | 0.31 % | $ 1.09 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 B | $ 184.06 | 0.16 % | $ 20.4 B | USA |
 |
Fulgent Genetics
FLGT
|
467 M | $ 28.38 | -0.49 % | $ 858 M | USA |
 |
Organovo Holdings
ONVO
|
3.1 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
9.12 M | - | -16.95 % | $ 1.54 M | USA |
 |
Pacific Biosciences of California
PACB
|
1.41 B | $ 2.33 | 4.69 % | $ 591 M | USA |
 |
PerkinElmer
PKI
|
14.1 B | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
16.8 M | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
8.7 M | $ 24.56 | 8.81 % | $ 31.9 M | USA |
 |
Personalis
PSNL
|
254 M | $ 10.09 | 4.18 % | $ 598 M | USA |
 |
RadNet
RDNT
|
3.68 B | $ 79.11 | -1.13 % | $ 5.78 B | USA |
|
Centogene N.V.
CNTG
|
221 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Global Cord Blood Corporation
CO
|
243 M | - | - | $ 399 M | China |